Stay updated on Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A notice about NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” appears above the study record, with links to updates and FAQs.
    Difference
    0.6%
    Check dated 2026-10-25T13:08:45.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2, with no visible change to the study record content.
    Difference
    0.1%
    Check dated 2026-10-18T12:39:38.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T13:23:15.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The history now includes a new revision entry v3.7.0 and removes the previous v3.6.6 entry, updating the page’s revision tracking. This update pertains to metadata about the study record rather than its content or status.
    Difference
    0.1%
    Check dated 2026-09-20T15:39:30.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    A new revision entry v3.6.6 was added to the record history, replacing the previous v3.6.5 entry. This indicates an updated submission to the study record.
    Difference
    0.1%
    Check dated 2026-08-29T23:51:21.000Z thumbnail image
  6. Check
    79 days ago
    Change Detected
    Summary
    A new page revision v3.6.5 was added to the study record history, replacing the prior v3.6.4 entry.
    Difference
    0.1%
    Check dated 2026-08-08T22:20:32.000Z thumbnail image

Stay in the know with updates to Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page.